Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD Effects in Male Volunteers

NCT02914262 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

IBD

Interventions

DRUG: AKB-4924
OTHER: Placebo

Sponsor

Aerpio Therapeutics